{"id":"https://openalex.org/W1971011001","doi":"https://doi.org/10.1016/s0006-2952(99)00285-3","title":"Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor","display_name":"Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor","publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W1971011001","doi":"https://doi.org/10.1016/s0006-2952(99)00285-3","mag":"1971011001","pmid":"https://pubmed.ncbi.nlm.nih.gov/10591147"},"language":"en","primary_location":{"id":"doi:10.1016/s0006-2952(99)00285-3","doi":"https://doi.org/10.1016/s0006-2952(99)00285-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0006-2952(99)00285-3","pdf_url":null,"source":{"id":"https://openalex.org/S185534594","display_name":"Biochemical Pharmacology","issn_l":"0006-2952","issn":["0006-2952","1873-2968"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015286906","display_name":"Blandine Kedjouar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Blandine Kedjouar","raw_affiliation_strings":["Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033710836","display_name":"Sylvie Daunes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvie Daunes","raw_affiliation_strings":["Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044527855","display_name":"Berthold J Vilner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Berthold J Vilner","raw_affiliation_strings":["Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109400840","display_name":"Wayne D. Bowen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne D Bowen","raw_affiliation_strings":["Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027046091","display_name":"A. Kla\u00e9b\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210101257","display_name":"Softmat - Chimie des collo\u00efdes, polym\u00e8res & assemblages complexes","ror":"https://ror.org/0171mae58","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4210101257","https://openalex.org/I4210128300","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Klaebe","raw_affiliation_strings":["I.M.R.P.C., UMR C.N.R.S. 5623, Biological Organic Chemistry Group, University Paul Sabatier, 31062 Toulouse cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.M.R.P.C., UMR C.N.R.S. 5623, Biological Organic Chemistry Group, University Paul Sabatier, 31062 Toulouse cedex, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I134560555","https://openalex.org/I4210101257"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113626764","display_name":"Jean\u2010Charles Faye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Faye","raw_affiliation_strings":["Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001428889","display_name":"Marc Poirot","orcid":"https://orcid.org/0000-0002-5711-6624","observed_orcids":["https://orcid.org/0000-0002-5711-6624"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Marc Poirot","raw_affiliation_strings":["Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Endocrinology and Cellular Communication, INSERM U397, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5001428889"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"],"apc_list":{"value":3590,"currency":"USD","value_usd":3590},"apc_paid":null,"fwci":0.6384,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.60383775,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"58","issue":"12","first_page":"1927","last_page":"1939"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiestrogen-binding-sites","display_name":"antiestrogen binding sites","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sigma-2-receptor","display_name":"sigma-2 receptor","score":0.7720000147819519},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/receptor-binding-sites","display_name":"receptor binding sites","score":0.3269999921321869},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.7919999957084656},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5809999704360962},{"id":"https://openalex.org/keywords/microsomal-proteins","display_name":"microsomal proteins","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2776067312","wikidata":"https://www.wikidata.org/wiki/Q50429983","display_name":"Antiestrogen","level":5,"score":0.6675257682800293},{"id":"https://openalex.org/C2777052854","wikidata":"https://www.wikidata.org/wiki/Q7512419","display_name":"Sigma receptor","level":3,"score":0.6161771416664124},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5732375383377075},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.5450312495231628},{"id":"https://openalex.org/C2778049214","wikidata":"https://www.wikidata.org/wiki/Q7512234","display_name":"Sigma","level":2,"score":0.5224948525428772},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4902553856372833},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.455222487449646},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.4201023280620575},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.41716599464416504},{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.4114491641521454},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.38526037335395813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22623878717422485},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2219327688217163},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18398234248161316},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.08528062701225281},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000097605","descriptor_name":"Sigma-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0006-2952(99)00285-3","doi":"https://doi.org/10.1016/s0006-2952(99)00285-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0006-2952(99)00285-3","pdf_url":null,"source":{"id":"https://openalex.org/S185534594","display_name":"Biochemical Pharmacology","issn_l":"0006-2952","issn":["0006-2952","1873-2968"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical Pharmacology","raw_type":"journal-article"},{"id":"pmid:10591147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10591147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:inserm-00090780v1","doi":null,"is_oa":false,"landing_page_url":"https://inserm.hal.science/inserm-00090780","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biochemical Pharmacology, 1999, 58 (12), pp.1927-1939. ⟨10.1016/s0006-2952(99)00285-3⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1499672184","https://openalex.org/W1575998024","https://openalex.org/W1811956372","https://openalex.org/W1920484061","https://openalex.org/W1951533674","https://openalex.org/W1969759689","https://openalex.org/W1986954201","https://openalex.org/W1988441067","https://openalex.org/W1988832560","https://openalex.org/W1992768650","https://openalex.org/W1994224293","https://openalex.org/W2000748188","https://openalex.org/W2001164731","https://openalex.org/W2001369831","https://openalex.org/W2004096658","https://openalex.org/W2026692772","https://openalex.org/W2036010230","https://openalex.org/W2044954204","https://openalex.org/W2046667419","https://openalex.org/W2050447602","https://openalex.org/W2062664011","https://openalex.org/W2074631079","https://openalex.org/W2075551789","https://openalex.org/W2089769584","https://openalex.org/W2091428068","https://openalex.org/W2093685198","https://openalex.org/W2102880496","https://openalex.org/W2106736820","https://openalex.org/W2109259730","https://openalex.org/W2124947957","https://openalex.org/W2125637243","https://openalex.org/W2126698050","https://openalex.org/W2128635872","https://openalex.org/W2164787803","https://openalex.org/W2265968143","https://openalex.org/W2400142744","https://openalex.org/W2407086176","https://openalex.org/W2466004060","https://openalex.org/W2529858948","https://openalex.org/W6634406569","https://openalex.org/W6640902082","https://openalex.org/W6713157103"],"related_works":["https://openalex.org/W2086229228","https://openalex.org/W2075551789","https://openalex.org/W3173500078","https://openalex.org/W2025956185","https://openalex.org/W2051993748","https://openalex.org/W4389008448","https://openalex.org/W2466004060","https://openalex.org/W2016407811","https://openalex.org/W1811956372","https://openalex.org/W2411334126"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}